Unknown

Dataset Information

0

Targeting cancer cell plasticity by HDAC inhibition to reverse EBV-induced dedifferentiation in nasopharyngeal carcinoma.


ABSTRACT: Application of differentiation therapy targeting cellular plasticity for the treatment of solid malignancies has been lagging. Nasopharyngeal carcinoma (NPC) is a distinctive cancer with poor differentiation and high prevalence of Epstein-Barr virus (EBV) infection. Here, we show that the expression of EBV latent protein LMP1 induces dedifferentiated and stem-like status with high plasticity through the transcriptional inhibition of CEBPA. Mechanistically, LMP1 upregulates STAT5A and recruits HDAC1/2 to the CEBPA locus to reduce its histone acetylation. HDAC inhibition restored CEBPA expression, reversing cellular dedifferentiation and stem-like status in mouse xenograft models. These findings provide a novel mechanistic epigenetic-based insight into virus-induced cellular plasticity and propose a promising concept of differentiation therapy in solid tumor by using HDAC inhibitors to target cellular plasticity.

SUBMITTER: Xie J 

PROVIDER: S-EPMC8418605 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7701581 | biostudies-literature
| S-EPMC9346003 | biostudies-literature
| S-EPMC3938524 | biostudies-literature
| S-EPMC9875085 | biostudies-literature
| S-EPMC8657235 | biostudies-literature
| S-EPMC8669164 | biostudies-literature
| S-EPMC3609040 | biostudies-literature
| S-EPMC4747187 | biostudies-literature
| S-EPMC5042013 | biostudies-literature
| S-EPMC3528656 | biostudies-literature